About
Treatments for Chronic Respiratory Illnesses
Areas of Focus
Categories
Small Molecule PharmaceuticalOther European
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
290
By Phase
PHASE1: 4PHASE2: 1
By Status
COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06677918Lead Sponsor
Clinical Trial Investigating the Effects of EP395 Following an Inhaled Endotoxin Challenge in Healthy Adults
PHASE1Recruiting
65 participants
Started: Feb 20, 2025 · Completed: Jun 30, 2026
NCT06118684Lead Sponsor
Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin
PHASE1Completed
37 participants
Started: Oct 23, 2023 · Completed: Jan 2, 2024
NCT05572333Lead Sponsor
Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD
PHASE2Completed
61 participants
Started: Nov 22, 2022 · Completed: Nov 24, 2023
NCT05516316Lead Sponsor
Clinical Trial Comparing the Pharmacological Effects of EP395 With Placebo in Healthy Adults
PHASE1Completed
49 participants
Started: Oct 11, 2022 · Completed: Jun 21, 2023
NCT04819854Lead Sponsor
Single and Multiple Ascending Dose Study With EP395
PHASE1Completed
78 participants
Started: Apr 5, 2021 · Completed: Mar 22, 2022
Locations (1)
Headquarters
Reykjavík, Iceland
Map
Loading map...